UPDATE: Ironwood (IRWD), Forest (FRX) Win FDA Approval for Linzess
Tweet Send to a FriendGet Alerts IRWD Hot Sheet
Trade IRWD Now!
(Updated - August 30, 2012 10:59 AM EDT)
Ironwood Pharmaceuticals (NASDAQ: IRWD), Forest Labs (NYSE: FRX) win FDA approval for Linzess to treat irritable bowel. (NOTE: Shares of IRWD were halted)
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Ironwood Pharmaceuticals (NASDAQ: IRWD), Forest Labs (NYSE: FRX) win FDA approval for Linzess to treat irritable bowel. (NOTE: Shares of IRWD were halted)
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Ironwood Pharm (IRWD) Announces 10.5M Common Offering
- Celgene (CELG) Granted FDA Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer
- Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
Create E-mail Alert Related Categories
FDA, Hot FDA News, Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
